EN
A randomized controlled trial of closure or non-closure of subcutaneous fatty tissue after midline vertical incision
Abstract
Background/Aim: There are limited studies that evaluate the closure of subcutaneous tissue, particularly among gynecologic oncology patients, a group with a high rate of obesity and more co-morbidities. This prospective randomized controlled study aimed to assess the effects of subcutaneous closure versus non-closure on wound complication rate in patients with subcutaneous tissue thicknesses of more than >4 cm.
Methods: All patients with a subcutaneous tissue depth≥4 cm measured with ultrasonography and undergoing gynecologic surgery via a midline vertical incision from February 2019 to March 2020 in the gynecologic oncology department at a teaching hospital were considered for inclusion. Patients were intraoperatively and sequentially randomized as 1:1 only when the measurement of subcutaneous tissue depth was verified to be 4 cm or more.
Results: A total of 82 patients who underwent randomization were assigned to undergo or not undergo subcutaneous closure with sutures (41 patients each). Subcutaneous wound depth (mean: 6.36 cm, range: 4-11 cm), vertical incision length (mean: 24.32 cm, 12-36 cm), body mass index (33.82 kg/m2, 19.6-33.82 kg/m2) were similarly distributed between the groups (P>0.05 for all). Wound complications were observed in 17 (20.7%) patients. Wound infection occurred in two patients in the closure group as compared to three patients in the control group (P=0.644). Seroma and wound dehiscence were seen more often in the control group, but neither of these findings reached statistical significance (P=0.077, P=0.284).
Conclusion: We found no significant differences in the rate of surgical wound complications with suture approximation of the subcutaneous tissue in patients with 4 cm or more subcutaneous thickness undergoing gynecologic surgery via a vertical midline incision.
Keywords
References
- 1. Nugent EK, Hoff JT, Gao F, Massad LS, Case A, Zighelboim I, et al. Wound complications after gynecologic cancer surgery. Gynecologic oncology. 2011;121:347–52.
- 2. Çakmak BD, Dündar B, Türker ÜA, Temur M, Özdemir H, Üstünyurt E, et al. Evaluation of risk factors for surgical site infection after cesarean section. J Surg Med. 2020;4:960-4.
- 3. Soper DE, Bump RC, Hurt WG. Wound infection after abdominal hysterectomy: effect of the depth of subcutaneous tissue. American journal of obstetrics and gynecology. 1995;173:465-71.
- 4. Vermillion ST, Lamoutte C, Soper DE, Verdeja A. Wound infection after cesarean: effect of subcutaneous tissue thickness. Obstet Gynecol. 2000;95:923-6.
- 5. Witte MB, Barbul A. General principles of wound healing. Surgical Clinics of North America. 1997;77:509-28.
- 6. Cardosi RJ, Drake J, Holmes S, Tebes SJ, Hoffman MS, Fiorica JV, et al. Subcutaneous management of vertical incisions with 3 or more centimeters of subcutaneous fat. American journal of obstetrics and gynecology. 2006;195:607-14.
- 7. Gurusamy KS, Toon CD, Davidson, BR. Subcutaneous closure versus no subcutaneous closure after non‐caesarean surgical procedures. Cochrane Database of Systematic Reviews. 2014;1.
- 8. Ethicon Johnson & Johnson . Coated Vycril Suture Product Information. 4 edn. 2015.
Details
Primary Language
English
Subjects
Obstetrics and Gynaecology
Journal Section
Research Article
Publication Date
May 1, 2021
Submission Date
March 29, 2021
Acceptance Date
May 25, 2021
Published in Issue
Year 2021 Volume: 5 Number: 5
APA
Bayrak, M., & Ozan, H. (2021). A randomized controlled trial of closure or non-closure of subcutaneous fatty tissue after midline vertical incision. Journal of Surgery and Medicine, 5(5), 426-428. https://doi.org/10.28982/josam.905018
AMA
1.Bayrak M, Ozan H. A randomized controlled trial of closure or non-closure of subcutaneous fatty tissue after midline vertical incision. J Surg Med. 2021;5(5):426-428. doi:10.28982/josam.905018
Chicago
Bayrak, Mehmet, and Hakan Ozan. 2021. “A Randomized Controlled Trial of Closure or Non-Closure of Subcutaneous Fatty Tissue After Midline Vertical Incision”. Journal of Surgery and Medicine 5 (5): 426-28. https://doi.org/10.28982/josam.905018.
EndNote
Bayrak M, Ozan H (May 1, 2021) A randomized controlled trial of closure or non-closure of subcutaneous fatty tissue after midline vertical incision. Journal of Surgery and Medicine 5 5 426–428.
IEEE
[1]M. Bayrak and H. Ozan, “A randomized controlled trial of closure or non-closure of subcutaneous fatty tissue after midline vertical incision”, J Surg Med, vol. 5, no. 5, pp. 426–428, May 2021, doi: 10.28982/josam.905018.
ISNAD
Bayrak, Mehmet - Ozan, Hakan. “A Randomized Controlled Trial of Closure or Non-Closure of Subcutaneous Fatty Tissue After Midline Vertical Incision”. Journal of Surgery and Medicine 5/5 (May 1, 2021): 426-428. https://doi.org/10.28982/josam.905018.
JAMA
1.Bayrak M, Ozan H. A randomized controlled trial of closure or non-closure of subcutaneous fatty tissue after midline vertical incision. J Surg Med. 2021;5:426–428.
MLA
Bayrak, Mehmet, and Hakan Ozan. “A Randomized Controlled Trial of Closure or Non-Closure of Subcutaneous Fatty Tissue After Midline Vertical Incision”. Journal of Surgery and Medicine, vol. 5, no. 5, May 2021, pp. 426-8, doi:10.28982/josam.905018.
Vancouver
1.Mehmet Bayrak, Hakan Ozan. A randomized controlled trial of closure or non-closure of subcutaneous fatty tissue after midline vertical incision. J Surg Med. 2021 May 1;5(5):426-8. doi:10.28982/josam.905018